Towards the enzymatic synthesis of oligonucleotides | Manufacturing Chemist
By early 2020, ten oligonucleotide drugs had received US FDA regulatory approval; with many more in the pipeline, it’s only fair to say that this drug class is becoming big business.
Access the full article featured in Manufacturing Chemist below: